Sleep apnea and snoring affect one and three people. If not addressed, obstructed sleep apnea can lead to serious health issues including diabetes, heart attack, hypertension, and glaucoma. Most therapy to address sleep apnea has been centered around invasive CPAP machines. Signifier Medical Technologies is a med-tech startup focused on non-invasive solutions for sleep-disordered breathing conditions. In February, the company received FDA approval for eXciteOSA, a medical device that provides neuromuscular stimulation to the tongue to address the conditions causing sleep apnea. Unlike other treatments, the device is used during the day and not while the patient is sleeping, resulting in increased comfort and convenience. 2- minute treatments have been shown to drastically improve the quality of sleep and reduce obstructive sleep apnea and snoring. There is a connected app for the device that encourages patient adherence and also provides valuable data to clinicians. London TechWatch caught up with CFO Alastair Maxwell to learn more about the company’s groundbreaking treatment, strategic plans, and latest round of funding from investors that include Alan Howard, Segulah Medical Acceleration, Pioneer Healthcare Partners, and Angelus Partners.
Normally, when a startup matures it brings to consider inorganic growth paths of growth. Startups that acquire a number of businesses may soon be operating a holding company across several lines of business. Palta shakes this model up from the onset by focusing on building several brands concurrently focused on the health and wellbeing space. Approaching it this way has several advantages: products within the portfolio are able to benefit from shared user bases, knowledge transfer from what’s working and not working, funding, shared infrastructure, and shared resources. The company currently operates Flo.Health, Zing Fitness Coach, Voir, Prisma Labs, and Simple Fasting; boasting more than 2.4M paid users with the plans to launch and acquire new applications covering more segments. This fluid model allows Palta to operate at the intersection of private equity, venture studio, incubator, and app maker. London TechWatch caught up with CEO and Cofounder Yuri Gurski to learn more about building a vertically integrated health and wellness cofounding company, the startup’s future plans, recent round of funding from investors that include VNV Global and Target Global.
The mental health crisis has a hidden toll on employers; depressed employees miss an increased number of workdays every year, employees with depressions lose 8% of work productivity on average, employees experiencing depression are two times more likely to leave a company than their non-depressed counterparts. With performance, engagement, and absenteeism all affected, companies are addressing the importance of providing mental health services to employees. Oliva is an online mental health platform that is designed for the needs of employers so that they can adequately address the mental well-being of their employees. The company uses a research-backed care model to provide service to employees rather than just connecting them with a therapy provider. Sessions can seamlessly be booked, with a slack integration, in just a few clicks where the employee is connected to a vetted specialist that is a part of the Oliva network and the employee is further supported by an in-house care team. Oliva also provides management training so that potential mental health issues can be detected early before they have a significant impact on operations. London TechWatch caught up with CEO, serial entrepreneur, and Cofounder Javier Suarez to learn how his personal experience running a startup led to founding this company, the importance of investing in employee mental health, the company’s strategic plans, recent round of funding, and much, much more.
Isolation from the pandemic has been especially hard on older adults, many that are in need of some form of support (both large and small) for activities of daily living. Over the last decade, a record portion of the population has been turning 65 each year in the UK, fueled by baby boomers. The combination of these two factors has made home health care a pillar of the healthcare system to support the needs of the elderly population and their families. Lifted is a comprehensive home care management platform that makes it easy for families to access, use, plan for, and manage their home care needs. The home care industry is extremely fragmented and navigating the landscape can be difficult to find trusted providers. Lifted brings transparent, and reliable experience to the process with its own dedicated staff (other providers rely on contract workers), digital-first experience, and resources. London TechWatch caught up with CEO and Cofounder Rachael Crook to learn more about how her experience caring for her mother inspired the company, the state of the industry, strategic plans, and latest round of funding from investors that include Fuel Ventures, 1818 Venture Capital, Perivoli Innovations, the J.B. Ugland family office, Kluz Ventures through its new health affiliated fund Novit Ventures, and VOYAGERS HealthTech.
Thanks to loosening restrictions, we are beginning to see the many health benefits of CBD, at scale, for the first time, allowing people to reap the benefits of cannabidiol without the high. The plant extract is being added to countless items like toothpicks, breath sprays, and even cheeseburgers to help people alleviate stress, sleep better, and reduce anxiety. TRIP is a CBD brand focused on more manageable and convenient uses like drinks and oil. The company presently offers four CBD-infused drinks that are convenient on the go. TRIP also offers a line of CBD oils that are used by placing a drop under your tongue. Both products are available direct-to-consumer through the company’s website and through select retailers. London TechWatch caught up with Cofounder Olivia Ferdi to learn about how the brand came to fruition, international expansion, and recent round of funding from investors that include Christian Angermayer and Maria Raga.
70% of patients consider online reviews important when selecting a healthcare provider and 75% of people have searched for a physician online according to a recent survey from Patientpop. With reviews playing such a pivotal role in discovery, gathering reviews is not only essential as a marketing tool but also as a mechanism for clinicians to address issues that may be resulting in less than stellar patient satisfaction. Doctify is the tech-enabled healthcare review platform that provides both patients and healthcare providers with valuable insights. Founded by two physicians in 2015, the platform also offers patients the ability to schedule appointments and teleconsultations. Doctify is offered on a subscription basis to the healthcare provider and is free to use for patients. London TechWatch caught up with CEO and Cofounder Stephanie Eltz to learn more about the business, the company’s strategic expansion plans to further support its mission to keep both patients and healthcare providers informed, latest funding round from investors that include Keen Venture Partners, Amadeus Capital, Guinness Asset Management, and Tom Teichman.
The global fertility market is estimated to grow to ~$50B by 2030 with nearly 1/8 couples having trouble conceiving. Advances in technology are making reproductive health options more accessible from both a convenience and affordability standpoint. Bea Fertility is a healthcare startup offering at-home fertility treatments via a kit offered through subscription. Traditional fertility options like IVF need to be done at a fertility center and come at exorbitant cost. Bea uses ICI, a technique that’s similarly effective to other treatment options, but only costs £300/month. The company is focused on supporting the entire conception journey and offers ovulation tracking, guidance, and an expert network. Presently pre-launch, Bea is in the process of gaining regulatory approval and expects to launch by the end of the year. London TechWatch caught up with CEO and Cofounder Tess Cosad to learn more about the importance of making fertility treatments accessible, the company’s upcoming launch, strategic plans, and recent round of funding from Calm/Storm VC and QVentures.
All human progress operating in service of bettered humanity is a response to one essential question: how do we evolve current knowledge into revolutionary concepts? In my four decades as an inventor, I have often found my response to this question to be one of medically-directed invention.
Scientific exploration of the microbiome represents the opening of one of the greatest new areas of science in decades, perhaps centuries. It has the potential to rival Einstein’s impact on physics or the double helix on understanding biology. While young, this area shows historic potential across a dizzying expanse of health and human experience.
Prokarium is developing Vesibax, an innovative, safe, and effective microbial immunotherapy (MI) for early-stage bladder cancer, a disease with afflicts over 550,000 individuals globally every year. CEO Ted Fjallman to learn more about Prokarium’s upcoming pipeline of novel therapies, its current focus, and recent funding round from investors that include Korea Investment Partners (KIP), Flerie Invest, Riyadh Valley Company (RVC), and the UK Government’s Future Fund.